---
$id: https://graph.org.ai/products/commodity/51143015
$type: Product
source: UNSPSC
code: "51143015"
title: "Nebracetam"
class: "51143000"
classTitle: "Nootropics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nebracetam

**UNSPSC Code**: 51143015
**Class**: [Nootropics](Nootropics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuroprotective agent with the molecular formula C12H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T30038QI8N, chemically known as 2-pyrrolidinone, 4-(aminomethyl)-1-(phenylmethyl)- but generally known as nebracetam, which bears US NIH Compound Identifier 65926. European Medicines Agency schedules Nebracetam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09176MIG. The term NEBRACETAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). NEBRACETAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nebracetam under HS 29337900 and SITC 51561. As of Q4 2014, NEBRACETAM remains the US FDA Preferred Term for this commodity. Nebracetam bears US NLM identifiers UMLS ID C0078459 and NCI Concept Code C66223. SMILES: C1C(CN(C1=O)CC2=CC=CC=C2)CN.

